Inspira Technologies Files Routine Registration Statement on Form F-3 with SEC

Inspira Technologies has filed a routine shelf registration statement on Form F-3 with the SEC, replacing a previous registration set to expire on August 18, 2025. The company specializes in life-support and diagnostic technologies, including the FDA-cleared INSPIRA ART100 system. Inspira is developing the INSPIRA ART500 and its HYLA blood sensor platform for continuous monitoring. The filing is part of the company's regular three-year renewal process.

Title: Inspira Technologies Renews Shelf Registration Statement

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN), a leading innovator in life-support and diagnostic technologies, has filed a routine shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission (SEC). This filing replaces the company's previous shelf registration statement, which was set to expire on August 18, 2025. The update is part of the company's regular three-year renewal process.

Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions. The company's FDA-cleared INSPIRA ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S. This system serves as a foundation for the development of the next-generation INSPIRA ART500, which is designed to deliver oxygenation while patients remain awake and spontaneously breathing.

Additionally, Inspira is advancing the HYLA™ blood sensor platform, offering continuous, non-invasive monitoring. The company's multiple cleared products, growing IP portfolio, and strategic streamlining of operations position it as an attractive platform within the life-support and MedTech landscape.

The routine shelf registration statement is a standard practice for companies that issue securities to maintain their public filing status. It ensures that the company remains compliant with SEC regulations and provides investors with updated information about the company's financial health and future prospects.

For more information, visit [Inspira Technologies' website](https://inspira-technologies.com).

References:
[1] https://finance.yahoo.com/news/inspira-clarifies-routine-nature-registration-134400490.html
[2] https://www.morningstar.com/news/globe-newswire/9508171/inspira-clarifies-routine-nature-of-registration-statement-on-form-f-3-filing-performed-every-three-years